No quick bonus with ASX

ASX's rights issue isn't a bargain reward. Still, shareholders have little choice but to take it up.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When ASX (ASX: ASX) resumed trading on Friday, it fell 6.1%. That came on top of  a 2.3% decline the day before the trading halt to announce its accelerated renounceable rights issue.

After trading as low as $32.51, shares in the Australian stock exchange operator finished the day down $2.13 at $33.15. With the US market Friday retracing almost half its previous day's gain and our market a bit baffled by the ASX's move, the price could well drop further.

Investors had to be registered owners of stock at 7 p.m. Sydney time Friday to be eligible for the issue. Given settlement delays, that precluded anyone buying on Friday from being on the books in time to take advantage of the $30 issue price, which represented a more than 16% discount on the prevous close. Offer documents go out Thursday, acceptances close July 5 and entitlements are market-tradeable in the meantime.

ASX shares closed at $39.38 just five weeks ago, have a year-high of $40 and before resuming trading on Friday were still up 14.83% on the year to date. The amount holders will be able to trade their rights for might not make up the difference between the current price and what it closed at before the announcement, let alone those recent highs.

Institutions took up 96% of their entitlments and rights not taken up by eligible shareholders were sold at $3.70. A high number of retail investors could be expected to take up the offer too.

The unexpected $553 million underwritten rights offer equals about 10% of the company's value. It is expected to be used to retire debt and to meet the expected increased costs of new capital standards for international clearing.

Foolish takeaway

The surprise rights issue isn't a windfall for retail shareholders, but it's how ASX uses its fattened balance sheet that will hopefully reward investors in the longer term.

If you're looking for a solid investment idea, click here now to get The Motley Fool's special FREE report, "3 Stocks For the Great Dividend Boom". The report lists the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading

Motley Fool contributor Andrew Ballard does not own shares in ASX. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »